(Q22252327)

PubMed

PubMed publication ID

18502035

7 February 2023

author name string

Maria Grazia Borrello

series ordinal

1

author given names

Maria Grazia

author last names

Borrello

1 reference

PubMed

PubMed publication ID

18502035

7 February 2023

Debora Degl’Innocenti

series ordinal

2

author given names

Debora

author last names

Degl'Innocenti

1 reference

PubMed

PubMed publication ID

18502035

Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy

7 February 2023

language of work or name

English

0 references

publication date

August 2008

0 references

published in

Cancer Letters

0 references

volume

267

0 references

issue

2

0 references

page(s)

262-270

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

RET and NTRK1 proto-oncogenes in human diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

The chemokine network: a target in cancer biology?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Species- and cell type-specific requirements for cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

RET tyrosine kinase signaling in development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

The significance of cancer cell expression of the chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Activation of RET tyrosine kinase regulates interleukin-8 production by multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

A microRNA expression signature of human solid tumors defines cancer gene targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

MicroRNA-155 is induced during the macrophage inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypox

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Tumor progression locus-2 is a critical regulator of pancreatic and lung inflammation during acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Distinct requirements for Ras oncogenesis in human versus mouse cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

A genetically defined model for human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

ret/PTC-1 Activation in Hashimoto Thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Expression of the Tpl2/Cot oncogene in human T-cell neoplasias

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

Chemokine regulation of normal and pathologic immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021

RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANLET.2008.03.060

7 January 2021